Drug Trial Radar · NCT02720744
Once-Nightly Sodium Oxybate for Treatment of Excessive Daytime Sleepiness and Cataplexy in Narcolepsy
Last checked: Nov 19, 2026Latest source record: Mar 22, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
212
Actual
Start
Nov 17, 2016
Primary completion
Mar 25, 2020
Study completion Mar 25, 2020
Sponsor
- Lead sponsor
- AvadelIndustry
- Sponsor type
- Industry
- First posted
- Mar 28, 2016
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 16 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether once-nightly FT218 is safe and effective for the treatment of excessive daytime sleepiness and cataplexy in subjects with narcolepsy.
Conditions
- Excessive Daytime Sleepiness
- Cataplexy
- Narcolepsy
Interventions
FT218Drug
PlaceboDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Maintenance of Wakefulness Test (MWT)Time frame: Study Visit 8 at 14 weeks
- Proportion of Patients That Were Very Much Improved or Much Improved on Clinical Global Impression of Improvement as Compared to ScreeningTime frame: Study Visit 8 at 14 weeks
- Number of Cataplexy Attacks at Visit 8 (Week 14) as Compared to BaselineTime frame: Visit 8 - Change from Baseline at 14 Weeks
Locations
57 sites in 6 countries. Site status is shown where the registry gives one.
Pinnacle Research Group LLC
Anniston, Alabama
University Sleep Disorder Center
Auburn, Alabama
Sleep Disorders Center of Alabama
Birmingham, Alabama
Baptist Health Center for Clinical Research
Little Rock, Arkansas
California Center for Sleep Disorders
Alameda, California
Stanford Sleep Medicine
Redwood City, California
SDS Clinical Trials Inc
Santa Ana, California
Alpine Research Center
Boulder, Colorado
Yale-New Haven Hospital's Sleep Medicine Center
North Haven, Connecticut
Pulmonary Disease Specialist, PA
Kissimmee, Florida
Sleep Medicine Specialists of South Florida
Miami, Florida
Sleep Medicine Specialist of South Florida
Miami, Florida
NeuroMedical Research Institute/Global Research Holdings, LLC
Panama City, Florida
FL Pediatric REsearch Institute
Winter Park, Florida
Florida Pulmonary Research Institute LLC
Winter Park, Florida
NeuroTrials Research Inc
Atlanta, Georgia
Sleep Disorders Center of Georgia
Atlanta, Georgia
Clinical Research Institute
Stockbridge, Georgia
OSF Healthcare Saint Francis Medical Center
Peoria, Illinois
Fort Wayne Neurological Center
Fort Wayne, Indiana
Norton Clinical Research Group
Louisville, Kentucky
Center for Sleep and Wake Disorders
Chevy Chase, Maryland
Infinity Medical Research
North Dartmouth, Massachusetts
Site not named
Chesterfield, Missouri
Site not named
St Louis, Missouri
Northwell Health
New Hyde Park, New York
Clinilabs Drug Development Corporation
New York, New York
Montefiore Sleep-Wake Disorders Center
The Bronx, New York
Research Carolina of Huntersville
Huntersville, North Carolina
Wake Research Associates, LLC
Raleigh, North Carolina
Sleep Management Institute Intrepid Research
Cincinnati, Ohio
University Hospitals Case Medical Center
Cleveland, Ohio
Ohio Sleep Medicine Institute
Dublin, Ohio
Geisinger Medical Center
Danville, Pennsylvania
Medical University of South Carolina - Institute of Psychiatry
Charleston, South Carolina
SleepMed Of South Carolina
Columbia, South Carolina
Sleep and Neurology Consultants
Houston, Texas
Sleep Therapy Research Center
San Antonio, Texas
NHMRC CEntre for Translational Sleep and Circadian Neurobiology
Sydney, New South Wales, Australia
Westmead Hospital
Sydney, New South Wales, Australia
Showing 40 of 57 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.